Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20215
20225
20235
20243
20258
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen2
The Third Xiangya Hospital of Central South University2
UCB Biopharma SRL2
Affiliated Hospital of Nantong University1
AstraZeneca1
Avistone Biotechnology Co., Ltd.1
Beijing VDJBio Co., LTD.1
Changchun BCHT Biotechnology Co.1
Chinese Academy of Medical Sciences1
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung3
Cardiovascular Diseases2
Connective Tissue Diseases2
Dermatomyositis2
Lupus Erythematosus, Systemic2
Angioedemas, Hereditary1
Arthritis, Rheumatoid1
Cerebrovascular Disorders1
Chickenpox1
Dermatitis, Atopic1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.